Immune to Cancer: The CRI Blog
-
How Immunotherapy Is Making an Impact in Breast Cancer
We spoke with Rebecca A. Shatsky, MD, about the current treatment landscape for patients with breast cancer,…
-
ASCO19 Day 5 Update: CAR T Cells for Pleural Cancers and More Melanoma News
The final day of ASCO19 covered CAR T cells for pleural cancers and long-term updates on several…
-
ASCO19 Day 4 Update: Kidney Cancer, Liver Cancer, Stomach Cancer, Esophageal Cancer, and Melanoma
The fourth day at ASCO19 highlighted immunotherapy strategies for patients with kidney cancer, liver cancer, stomach cancer,…
-
ASCO19 Day 3 Update: Immunotherapy for Brain Cancer, Ovarian Cancer, Lung Cancer, and Patients with HIV
The third day at ASCO19 highlighted immunotherapy strategies for patients with brain cancer, ovarian cancer, lung cancer,…
-
ASCO19 Day 2 Update: Biomarkers in Checkpoint Immunotherapy, Targeting Macrophages, and Cellular Immunotherapies
The second day at ASCO19 highlighted biomarkers that may have value in the context of PD-1 checkpoint…
-
ASCO19 Day 1 Update: Lung Cancer, Head and Neck Cancer, and the Cost of Immunotherapy
The opening day at ASCO19 discussed various immunotherapy combinations for head and neck cancer, a bispecific antibody…
-
Dr. Robert Schreiber and Interferon Gamma
By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has…
-
AACR19 Day 5 Update: Bispecific Antibodies, the Importance of “Helper” T Cells, and the Lloyd J. Old Award Lecture
Scientists tackled novel immunotherapy strategies that could potentially enable more patients with more types of cancer to…
-
AACR19 Day 3 Update: CAR T Cells, Vaccines, and Hope Against Pancreatic Cancer
In addition to advances involving CAR T cell therapy and vaccines, a CRI-funded trial revealed the promise…